Erbi Biosystems, Inc. — Form D
Erbi Biosystems, Inc. of WOBURN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-26. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-10-26
- Form: D
- Accession: 0001104659-20-118053
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2020-10-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-378810
Issuer
- Name: Erbi Biosystems, Inc.
- CIK: 0001753263
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 325 NEW BOSTON ST., WOBURN, MA, 01801
- Phone: 617-792-0524
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael Chiu | Director | Cambridge, MA |
| Mark Ehrman | Director | WOBURN, MA |
| Harry Lee | Director | WOBURN, MA |
| Kevin Lee | Director | San Francisco, CA |
| Michael Chiu | Executive Officer | Cambridge, MA |
| Harry Lee | Executive Officer | WOBURN, MA |
| Kevin Lee | Executive Officer | San Francisco, CA |
| Philip Lessard | Executive Officer | WOBURN, MA |
Other filings by this issuer (1)
More